BEONE MEDICINES LTD. Payments to Acquire Investments
BEONE MEDICINES LTD. (ONC) reported Payments to Acquire Investments of $15.58 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2023-11-09
- BEONE MEDICINES LTD. payments to acquire investments for the quarter ending 2023-09-30 was $4.00M, a 23.77% increase year-over-year.
- BEONE MEDICINES LTD. payments to acquire investments for the quarter ending 2023-06-30 was $10.52M, a 4.38% decline year-over-year.
- BEONE MEDICINES LTD. payments to acquire investments for the quarter ending 2023-03-31 was $1.06M, a 111.11% increase year-over-year.
- BEONE MEDICINES LTD. payments to acquire investments for the quarter ending 2022-09-30 was $3.23M, a 99.54% decline year-over-year.
- BEONE MEDICINES LTD. payments to acquire investments for fiscal 2020 was $5.69B, a 386.65% increase from fiscal 2019.
- BEONE MEDICINES LTD. payments to acquire investments for fiscal 2019 was $1.17B, a 55.64% decline from fiscal 2018.
- BEONE MEDICINES LTD. payments to acquire investments for fiscal 2018 was $2.64B.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $14.52M derived: sum of 2 quarters · filed 2023-11-09 | $15.58M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $10.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $11.58M 10-Q · filed 2023-08-02 | ||
| 2023-03-31 | $1.06M 10-Q · filed 2023-05-04 | |||
| 2022-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $14.23M derived: sum of 2 quarters · filed 2023-11-09 | $14.73M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $11.50M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $504.00K 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $705.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.30B derived: sum of 2 quarters · filed 2022-11-09 | $2.06B 10-Q · filed 2022-11-09 | $2.87B derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $592.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.36B 10-Q · filed 2022-08-08 | $2.17B derived: sum of 3 quarters · filed 2022-08-08 | $4.60B derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $764.16M 10-Q · filed 2022-05-09 | $1.57B derived: sum of 2 quarters · filed 2022-05-09 | $4.01B derived: sum of 3 quarters · filed 2022-05-09 | $5.15B derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $810.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.25B derived: sum of 2 quarters · filed 2021-11-04 | $4.38B derived: sum of 3 quarters · filed 2021-11-04 | $5.69B 10-K · filed 2021-02-25 |
| 2020-09-30 | $2.44B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.57B derived: sum of 2 quarters · filed 2021-11-04 | $4.88B 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.14B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.44B 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.31B 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $1.17B 10-K · filed 2021-02-25 | |||
| 2018-12-31 | $2.64B 10-K · filed 2021-02-25 |